$ALZN
Alzamend Neuro, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Atlanta, GA
ALZN chart
What traders are saying about $ALZN
Latest postsAlzamend Neuro, Inc. news
- Alzamend Neuro, Inc. Estimates – BOATS:ALZN
TradingView ·
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga ·
- Alzamend Neuro (ALZN) Upgraded to Buy: What Does It Mean for the Stock?
Yahoo Finance ·
- Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
- Alzamend Neuro Regains Compliance with Nasdaq Listing Standards
Yahoo Finance ·
- Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC
Yahoo Finance ·
- Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain
Yahoo Finance ·
- Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending
Yahoo Finance ·
- Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
Yahoo Finance ·
- Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions
Yahoo Finance ·
- Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital
Yahoo Finance ·
- Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
Alzamend Neuro, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$8.8M | -$4.5M | -$9.9M | -$14.9M |
| Diluted EPS | $-2.63 | $-11.32 | $-132.33 | $-22.89 |
| Total assets (year end) | $4.0M | $4.2M | $782,636 | $8.5M |
| Cash and equivalents (year end) | $2.7M | $3.4M | $282,867 | $7.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCurrent report (material event)
- 10-QQuarterly report
- S-1Registration statement
- 8-KCurrent report (material event)
- 10-KAnnual report
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 8-KCurrent report (material event)
- 10-QQuarterly report
- 8-KCurrent report (material event)
- DEF 14AProxy statement
- 10-QQuarterly report
About Alzamend Neuro, Inc.
- Ticker
- ALZN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Atlanta, GA
- Incorporated in
- DE
- Fiscal year end
- April 30
- SEC CIK
- 1677077
Frequently asked questions
What exchange is Alzamend Neuro, Inc. listed on?
Alzamend Neuro, Inc. trades on the Nasdaq under the ticker symbol ALZN.
What industry is Alzamend Neuro, Inc. in?
Alzamend Neuro, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Alzamend Neuro, Inc. headquartered?
Alzamend Neuro, Inc.'s business address on file with the SEC is in Atlanta, GA.
When does Alzamend Neuro, Inc.'s fiscal year end?
Alzamend Neuro, Inc.'s fiscal year ends on April 30.